Citizens Financial Group has reaffirmed its stock rating for Bicycle Therapeutics, maintaining an "outperform" designation. This decision reflects the firm's confidence in Bicycle Therapeutics' potential for growth and performance in the market. Investors and analysts will be closely monitoring the company's developments following this rating confirmation.
Related Articles
Don't miss out on breaking stories and in-depth articles.